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Background: The purpose of this study was to investigate the influence of locus of control on 
adherence to a treatment regimen among hypertensive patients.
Methods: The participants were 100 previously diagnosed hypertensive patients drawn from 
the Ituku-Ozalla University of Nigeria teaching hospital, using a purposive sampling technique. 
All participants were individually administered the Wallston, Wallston & Devellis (1978), 
Multidimensional Health Locus of Control (MHLC) scale, and Drug Adherence Questionaire 
(DAQ) by the researchers. A one-way factorial design and analysis of variance with unequal 
sample sizes were used to analyze the data.
Results: Internally-oriented patients adhered more to their treatment regimen than externally-
oriented patients, F(1.98) = 18.2 (P , 0.01).
Conclusion: Locus of control should be taken into consideration in the review of treatment 
packages for patients. This is because the efficacy of drugs depends to a reasonable extent on 
adherence to the schedule. If drugs are not taken as prescribed, their potency may be affected 
or wrongly assessed.
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Introduction
The various physiological conditions of the human organism have equilibrium points for 
normal functioning. Any deviation from the set points results in unpleasant experiences 
or pathological conditions that could lead to death if not restored. Some of these physi-
ological conditions include temperature, hydrogen-ion balance, blood sugar level, and 
blood pressure. Of these physiological conditions, blood pressure was of interest in the 
present study. Blood pressure appears to have devastating consequences if the normal 
level is not maintained.1 This is because it is blood pressure that indicates the volume 
and speed with which blood circulates in the system. This seems to have implications 
for the amount of oxygen, sugar, and other products that circulate in the system for 
normal physiological functioning. Blood pressure indicates the force of blood flowing 
against the walls of arteries. It is measured with a sphygmomanometer, and the high-
est pressure in the cycle is recorded when the heart contracts or beats to pump blood. 
This is called systolic blood pressure. When the heart relaxes between the beats, the 
lowest pressure recorded is known as diastolic blood pressure. Thus, the blood pres-
sure measurement yields two numbers, ie, systolic and diastolic pressure.   According 
to Morrow,2 a typical normal blood pressure reading for adults is 120/80 mmHg and 
90/60 mmHg for children. Vander et al3 noted that the dividing line between normal 





above a level of 140/90 mmHg could be considered to be 
high, and this condition is known as hypertension.
Hypertension
High blood pressure, ie, hypertension, indicates that blood is 
traveling through the arteries at a pressure too high for good 
health. High blood pressure has been linked with death, as a 
result of stroke, heart attack, and kidney failure. Untreated 
hypertension can affect cognitive functioning, and cause 
problems with hearing, memory, attention, abstract thinking, 
mental flexibility, and other cognitive skills.1,4,5 According to 
Giles and Materson,6 hypertension is often the precursor to 
congestive heart failure, chronic occlusive peripheral vascular 
disease, renal failure, and stroke. The most dangerous aspect 
of this pathological condition is that it has no characteristic 
symptoms, hence it is referred to as a “silent killer”,7 and is 
diagnosed only when blood pressure is measured. In more 
than 90% of cases, the etiology is unknown.8 It has been 
reported that 50 million people in the US are hypertensive, 
and 600 million people are affected worldwide.9 In Nigeria, 
the incidence seems high.10 The World Health Organization 
has reported that the total estimated deaths from cardiovas-
cular disease for Nigeria in 2004 was 20,1500, and 10,700 
of these cases were recorded as hypertensive heart disease. 
This ranks Nigeria at the sixteenth position globally, and first 
in sub-Saharan Africa. Hospital admissions reflect the high 
prevalence of hypertension in these countries. Cases of stroke, 
heart attack, and cardiac arrest abound. Cappuccio et al11 
observed a rapid increase in the prevalence of hypertension 
in adults in Africa. Onwubere12 noted that both diastolic and 
systolic pressures affect the cardiovascular system. Sudden 
cardiac deaths have been reported in offices, homes, hotels, 
and even on football pitches.13 Quiping et al14 asserted that 
high blood pressure is an important preventable cause of pre-
mature death from heart disease and stroke. The etiological 
factors have remained speculative, especially for essential 
hypertension. There is no known cause, except that it has 
been linked with genetic predisposition,15 genetic mutation,16 
negative emotions,17 excessive salt intake, lack of exercise, 
smoking, poor diet, obesity,18 lack of potassium and/or 
calcium, sedentary lifestyle, Type A personality, and stress. 
This variant accounts for 95% of hypertension cases, and is 
referred to as primary hypertension.19 The remaining 5% are 
classified as secondary hypertension, resulting from other 
conditions, including renal and endocrinal disorders,19 or can 
be drug-induced, and is more common generally among city 
dwellers20 and also in urban dwellers in Nigeria.21 Hyperten-
sion has been associated with a number of risk   factors. Efforts 
should be made to reduce, control, and normalize blood 
pressure as much as possible. Because hypertension has been 
linked with many causes, there is a wide range of treatment 
available, including medication, lifestyle modification, ie, 
weight loss, exercise, dietary adjustment, salt restriction, 
quitting smoking, and reducing alcohol intake. The efficacy 
of treatment depends largely on the patient being able to 
adhere to the treatment regimen.
Adherence refers to the extent to which a person’s 
behavior with regard to taking medication, following a diet, 
and/or implementing lifestyle changes corresponds with the 
recommendation from a health care provider.22,23 Adherence 
to therapy is a potent factor in determining the success of a 
treatment regimen. Poor adherence reduces optimum clini-
cal benefits from drug use, as well as the overall effective-
ness of the health care system. According to Bernard and 
Bloom,24 adherence is a major problem in effective control of 
hypertension, despite the availability of effective drugs and 
knowledge of etiology. Burnier25 contended that compliance 
with medication is a critical factor in blood pressure control. 
Adherence to a treatment regimen is a major psychological 
factor in a patient’s recovery. It is a complex behavioral pro-
cess and is related to people’s knowledge and beliefs about 
their illness, their motivation to manage it, confidence in their 
ability to engage in illness-management behaviors, expecta-
tions regarding the outcome of treatment, and knowledge of 
the consequences of poor adherence.
Many hypotheses have been proposed to explain the 
phenomenon of adherence. One of these is the health belief 
model. The health belief model postulates that health behav-
iors are expressions of health beliefs. The model is designed 
to predict a person’s health behaviors, which include the 
use of health services, behaviors that justify an interven-
tion   strategy/program, as well as alteration of maladaptive 
behaviors. The health belief model components include the 
person’s own perception of their susceptibility to disease, 
perceived likelihood of contracting a disease, perceived 
benefits of care, perceived barriers to preventive behavior, 
and internal and external stimuli that enable appropriate 
health behavior.26 In other words, the health belief model 
predicts health-related behaviors in terms of certain belief 
patterns. Based on this model, adherence to a medical regi-
men depends on the individuals’ belief about certain aspects 
of his/her illness. Therefore, the person’s belief with regards 
to perceived susceptibility to illness, severity of illness, 
and the benefits and risks of adherence, play an important 
role in whether or not an individual would comply with a 




Locus control on adherence to antihypertensives
The patient’s ability to take drugs and their other   treatment 
perceptions according to dosage and dosage schedule have 
implications for recovery from illness. Omeje27 noted that the 
effectiveness of drug therapy for any pathological condition 
could be accurately assessed if the patient adhered strictly 
to the treatment dosage and schedule. Poor adherence has 
been blamed for low treatment success, and has been found 
to contribute to lack of blood pressure control in more than 
two-thirds of patients, and is a critical factor in determina-
tion of response to antihypertensive medication.28 Gerbino 
et al29 posited that blood pressure control is significantly 
better with improved compliance with medication. Snider 
and Oparil30 contended that people with high blood pres-
sure under good control can go on to live a healthy life as 
long as they are willing to follow a doctor’s instructions. 
  However, it has been observed that some people do not 
always adhere to their prescriptions, hence the condition   
persists.   Stephenson31 stated that noncompliance rates can 
range from 20% to 80%. Dubbar-Jacob et al32 noted that 
noncompliance may be responsible for as many as half of 
antihypertensive drug failures.33 observed that among patients 
with hypertension, 20% take less than 80% of their medica-
tion, and that this is a major obstacle to good control of high 
blood pressure. Gottlieb34 reported that most patients do not 
follow their doctor’s instructions. Adherence is a human 
behavior with many determining factors, and critical among 
these is locus of control.
Rotter35 defined locus of control as a person’s belief 
about the location of controlling forces in their lives. It is 
believed that human behavior is caused by many factors, 
but people differ in their beliefs about what causes it. Some 
people believe that events in their lives are caused by their 
own attitudes and behavior, while others believe that they are 
controlled by forces outside themselves. This belief as the 
cause of behavior or events has yielded two dimensions of 
location of causality, hence we have an internal dimension 
and an external dimension.
The internal dimension seems to imply an active and 
controlling approach to life. An internally-oriented person is 
one who approaches situations with a direct and alert posture. 
The individual believes that events in their life are under their 
own control and that what happens to them results from their 
own actions, personality characteristics, innate predispositions, 
and abilities. Externally-oriented persons, on the other hand, 
believe that events in their lives are controlled by external 
forces, such as fate, luck, God, or imperatives that are beyond 
their control.36 Internally-oriented individuals feel effective in 
pursuit of their goals, and are ready to take responsibility for the 
outcome of their actions, whereas externally-oriented individu-
als believe that efforts do not necessarily result in reward.
Moreover, individuals who tend to perceive reinforcement 
as contingent upon their own behavior, are more likely to 
engage in adaptive behaviors in order to improve themselves 
and are likely to attend to, learn, and remember informa-
tion that will affect future goals.37 Thus, locus of control in 
the health setting implies a generalized expectation about 
whether one’s health is controlled by one’s behavior or by 
forces external to self.38 Rodin39 asserted that an individual 
with a high perceived health locus of control may have 
better health because he or she is more likely to take health-
enhancing actions.
Locus of control has been linked to a wide range of behav-
iors, with internality associated with a number of adaptive 
behaviors,40 taking steps to improve health,41 ability to stop 
smoking,42 ability to lose excess weight,43 get dental checkups,44 
and adherence to the recommendations arising from a medical 
checkup.45 Lefcourt46 contended that locus of control mediates 
any actions taken to prevent health problems. It correlates 
positively with conformity, attitude change, and achievements.47 
Externally-oriented individuals believe that illness is caused 
by something or someone elsewhere, while internally-oriented 
individuals believe that illness is caused by their own unhealthy 
attitudes and actions. Morowatisharifabadi et al48 found that a 
positive association exists between internal locus of control and 
adherence to a treatment regimen in diabetic patients. Because 
previous studies have shown that locus of control correlates 
positively with behaviors that affect human health, the present 
study investigated the effect of locus of control on adherence 
to a treatment regimen by patients diagnosed with hypertension 
in the Igbo cultural environment in   Nigeria. 
Hypothesis
It was hypothesized that locus of control would have a 
significant effect on adherence to a treatment regimen, such 




A total of 100 participants (54 males and 46 females) 
diagnosed by physicians as hypertensive, with blood 
  pressure .140/90 mmHg, were recruited for this study. 
Using a purpose-sampling technique, they were drawn from 
the Outpatients Department of the University of Nigeria 
Teaching Hospital, Enugu, in southeastern Nigeria. They were 





age of the participants was 42 years, with senior secondary 
school certificate as the minimum educational qualification. 
They were all married, had an Igbo cultural background, 
and were working in government institutions. Of the 
100   participants, 53 were deemed to be internally-oriented and 
47 to be   externally-oriented on the basis of the instruments 
  administered to the patients in the waiting room.
instruments
Two set of instruments were used for the study, ie, the Multi-
dimensional Health Locus of Control (MHLC) scale devised 
by Wallston et al38 and a drug adherence questionnaire (DAQ, 
see Appendix) developed by the investigators.
The MHLC scale is an 18-item questionnaire with six 
response options designed to determine the degree to which 
individuals believe that their health is controlled by internal 
or external factors. It reflects the tendency to see oneself 
as having a strong influence over events (internal orienta-
tion) in contrast with seeing oneself as being influenced by 
events that are out of one’s control (external orientation). 
It is scored in the external direction, so that the higher the 
subject’s scores, the more external the subject is. To estab-
lish the reliability and validity of this instrument in the Igbo 
cultural environment in southeastern Nigeria, 20 patients 
from Park Lane Hospital, Enugu, were administered the 
instrument. A split-half reliability coefficient of 0.78 was 
obtained using the Pearson product moment correlation. A 
corrected value of 0.88 using the Spearman Brown formula 
was obtained, indicating very high reliability. A validity 
index of 0.9 was obtained using intrinsic validity.49 The 
instrument was considered reliable and valid for research 
in Nigeria.
The DAQ is a 16-item questionnaire with four resp-
onse options, ranging from 4 (almost always), 3 (often), 
2   (sometimes) to 1 (rarely) developed by the   researchers. 
The scoring was reversed for items 6, 12, 13, and 14, which 
were negatively worded. A highest possible score of 64 
and lowest score of 16 could be obtained; scores in the 
range 16–40 indicate low adherence, while a score of $40 
indicates high adherence. The median point was 40, so was 
chosen as the norm for classifying the participants, and was 
used to determine the degree to which patients adhered to 
their treatment regimen. A split-half reliability coefficient 
of 0.71 was obtained using the Pearson product moment 
correlation, and a Spearman Brown formula of 0.83 was 
obtained. For validity, the items were subjected to scrutiny 
by five professionals, two clinical psychologists, and three 
medical practitioners, who agreed that the items were valid. 
Intrinsic validity49 was also   calculated, and a value of 0.91 
was obtained. The   questionnaire was considered reliable and 
valid for the study.
Procedure
The researchers engaged the services of the nurses attending 
to the patients as they came to consult with their doctors. 
After obtaining a letter of permission from the chief medical 
director of the University of Nigeria teaching hospital, Enugu, 
the researchers went to the Outpatients Department and met 
the chief nursing officer in charge of the unit, explained the 
purpose of the research, and asked the nurses to help them 
in administering the instrument. The chief nursing officer 
agreed, and allowed the researchers to interact with the nurses 
on duty each day. After that, the researchers were allowed 
access to the patients, and the instruments were adminis-
tered individually while they were in the waiting room. This 
exercise lasted for six weeks. At the end, 100 copies of the 
instrument were able to be used for the study, with 20   copies 
of the instrument excluded because of being incorrectly 
completed.
statistical analysis
A single design was adopted, and a one-way analysis of 
variance and F-statistics with unequal sample sizes were 
used for the study. This statistic analysis was chosen because 
the independent variable had two levels (external locus of 
control versus internal locus of control) and the sample size 
was more than 30.
Results
Table 1 shows the mean and standard deviation scores 
for adherence to the prescribed regimen which indicate 
that internally-oriented individuals adhered better than 
  externally-oriented individuals. Table 2 showed that the 
locus of control had a significant effect on adherence to 
treatment, F(1.98) = 18.20 (P , 0.001). This confirms the 
hypothesis that locus of control would have a significant 
effect on adherence to a treatment regimen among hyper-
tensive patients.
Table 1 Mean scores and standard deviations of internals and 
externals on drug adherence questionnaire
Mean  Standard deviation
external 47.57 5.39
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Discussion
Our results show a significant difference between internally-
oriented and externally-oriented patients for adherence to the 
treatment regimen. This supports the hypothesis that there 
would be a significant effect of locus of control on adher-
ence, such that internally-oriented individuals would adhere 
more to their treatment regimen than externally-oriented 
individuals. This finding is consistent with the results of 
previous studies showing that internally-oriented patients 
seek information, see themselves as responsible for mainte-
nance or improvement of their physical health, know more 
about conditions that cause poor health, and are more likely 
to take steps to improve or maintain their health,41 engage 
in health-protective behaviors,50 stop smoking,42 and lose 
excess weight.43 Carlise-Frank40 posited that the relationship 
between locus of control and health-facilitating behaviors 
as a whole point to an internal locus of control as a mediat-
ing factor for any action taken to prevent health problems. 
  Internally-oriented patients are more likely to engage in posi-
tive health behaviors and generally have good health, engage 
in preventive health care activities, cope adequately with 
illness, and have good adherence to a medical regimen.
Moreover, the results of this study have contributed to 
our knowledge about the power of locus of control in terms 
of human actions. The location of the cause for actions has 
implications for what one does and how one does it.   Medical 
practitioners should take into consideration the locus of 
control variable when they interact with their patients, 
particularly with regard to patient assessment and drug 
prescribing. Recognizing the locus of control orientation of 
their patients would enable health care providers to assess 
the efficacy of the drugs and treatment modalities prescribed 
more effectively, and to ensure that an effective treatment 
regimen is maintained and avoid unnecessary expenditure. 
Thus, if the patient is internally-oriented, it will be most likely 
the drugs would be taken as prescribed, vis-à-vis dosage and 
dosage schedule. Also, because locus of control has been 
shown to be a powerful factor influencing human behavior, 
it is suggested that agents of socialization should encourage 
children to be responsible for their own actions and the out-
comes, ie, to become internally-oriented. If children grow 
into internally-oriented adults, it is more likely that they will 
engage in behaviors that foster good health and, in the event 
of physical or psychological health breakdown, they would 
engage in actions that would return them to their status quo. 
In addition, clinical and health psychologists should take note 
of the effect of locus of control on adherence to a treatment 
regimen when they are interacting with their clients. Any 
psychotherapy technique, especially if built upon learning 
principles, should take the dimension of locus of control of 
their clients into consideration. This should be done during 
assessment in order to predict the likelihood that the client 
would be faithful to the terms of the therapy contract and 
to assess the efficacy of the technique adopted in helping 
the client deal with any psychological issues. This would 
also enable the clinician to plan a modification program 
to facilitate a change in orientation in case the client is 
externally-oriented.
Although this research focused on hypertensive patients, 
it could be applied to other pathological conditions, espe-
cially ones warranting prolonged treatment, eg, acquired 
immunodeficiency syndrome, asthma, and cancer. It has 
been shown that noncompliance with drug therapy, which is 
crucial for maintenance of vital physiological functioning, is 
more likely to have serious consequences than compliance 
with drug therapy intended for relief of symptoms.51 Thus, 
any factor that negatively influences adherence should be 
considered in planning health care services, given that good 
adherence forestalls relapse, complications, and inaccurate 
assessment of drug efficacy.
Although our results support the hypothesis that locus 
of control influences adherence to treatment, the study 
has its weakness. The population and sample size are 
small compared with the number of possible pathological 
conditions and the size of the general patient population, 
so it is suggested that further studies be carried out. To 
broaden the applicability of this finding, a larger sample 
size is advocated. Other variables, including locality, age, 
gender, socioeconomic background, personality attributes, 
and other clinical conditions should be studied in relation 
to adherence and locus of control. Findings from such 
research would not only widen the areas of application of 
the results, but would also strengthen the validity of our 
observations and would inevitably lead to development of 
the health sector and actualization of good health for every 
citizen of any nation.
Table 2 summary of one-way analysis of variance for the difference 
between internally-oriented and externally-oriented patients on 
the drug adherence questionnaire
Sov SS Df MS F  P 
A 550.66 1 550.66 18.20 ,0.001
s/A 2965.174 98 30.257
T 3515.834 99






Adherence to a drug regimen is a very important factor in 
drug efficacy. It is a very important aspect of behavior that 
promotes good health and promotes longevity. It helps to 
forestall economic waste and the psychosocial consequences 
of nonadherence. It also helps to assess accurately the degree 
of drug efficacy.
The importance of adherence to treatment cannot be 
overemphasized. Studies have shown that adherence to drugs 
contributes a great deal, not just to pharmaceuticals but also 
in treatment. For instance, Dracup and Meleis52 reported that 
80% compliance with a treatment regimen for hypertension 
was shown to lower blood pressure effectively, whereas a 50% 
compliance rate was ineffective in lowering blood pressure. 
Urquart51noted that reliance on intention-to-treat analysis, 
whereby one ignores doses actually taken and analyzes the 
results on the basis of the treatment to which patients are 
assigned in drug trials, has created a number of problems and 
biased estimates of drug efficacy. In other words, even in the 
pharmaceutical industry, adherence must be considered when 
developing new drugs. Therefore, it is recommended that any 
variable that has an impact on adherence should be taken into 
consideration. Based on the findings of this study, locus of 
control in patients should be kept in mind for all aspects of the 
health care delivery system, starting from laboratory investiga-
tions where collection of a specimen requires certain behaviors 
eg, the time of day at which the specimen needs to be collected. 
In obstetrics and gynecology, adherence to antenatal instruc-
tions is   necessary. In surgery, it is also important. In conclusion, 
because research has shown the importance of adherence in 
health care and the present study shows the influence of locus 
of control, health care providers should take these variables 
into consideration when planning and implementing health 
policies in order to achieve the desired objectives.
Disclosure
The authors report no conflicts of interest in this work.
References
1.  American Heart Association. Heart and Stroke: Statistical Update. 
  Dallas, TX: American Heart Association; 2001.
2.  Morrow R. Mayo Clinic Family Health Book. Maya; Foundation for 
Medicine Education and Research. 1990;25:699–712.
3.  Vander A, Sherman J, Lucina D. Human Physiology: The Mechanism 
of Body Function. Boston, MA: McGraw-Hill; 2001.
4.  Larson DE. Mayo Clinic Family Health Book. Mayo Foundation for 
Education and Research. 1990;2:796–801.
5.  Taylor SE. Health Psychology. 5th ed. New York, NY: McGraw-Hill; 
2003.
  6.  Giles TD, Materson BJ. Testing Stage 2 hypertension. J Clin Hypertens 
(Greenwich). 2005;7:464–470.
  7.  Columbia Encyclopedia. Hypertension. Available from: http://www.
answers.com/topic/hypertension. Accessed September 27, 2010.
  8.  Snider AJ, Oparil S. Hypertension. Chicago, IL: Building Press; 
1976.
  9.  World Health Organization. Cardiovascular Disease Prevention and 
Control; 2002.
  10.  Mathers CD. Uncertainty and data availability for the global burden 
of disease estimates: 2000–2002. Evidence and Information for Policy 
Working Papers. Geneva World Health Organization. Available at http://
www.who.int/evidence/bod.
  11.  Cappuccio FP, Micah FB, Emmett L, et al. Prevalence, detection, 
management and control of hypertension in Ashanti, West Africa. 
Hypertension. 2004;43:1017–1022.
  12.  Onwubere B. Essentials of Hypertension Management. Enugu Campus: 
Institute for Development Studies, University of Nigeria; 2005.
  13.  Ifeagwazi CM. A review of aspects of clinical management 
of   hypertension. Journal of Sociological Sciences. 2004;2: 
90–100.
  14.  Quiping Gu V, Burt L, Paulose-Ram R, Yoon S, Gillium RF. High 
blood pressure and cardiovascular disease mortality and risk among US 
adults: The Third National Health And Nutrition Examination Survey 
mortality follow-up study. Ann Epidemiol. 2008;18:302–309.
  15.  Smith TW, Turner CW, Ford MH, et al. Blood pressure reactivity in 
adult male twins. Health Psychol. 1987;6:209–220.
  16.  Dickson ME, Sigmund CD. Genetic basis of hypertension: Revisiting 
angiotensinogen. Hypertension. 2006;48:14–20.
  17.  Jonas BS, Lando JF. Negative affect as a prospective risk factor for 
hypertension Psychosom Med. 2000;62:188–196.
  18.  Wofford MR, Hall JE. Pathophysiology and treatment of obesity 
hypertension. Curr Pharm Des. 2004;10:3621–3637.
  19.  Wikipedia. Hypertension. Available from: http://www.answers.com. 
Accessed on September 27, 2010.
  20.  Shyrock H. Modern Medical Guide. Boise, ID: Pacific Press Publishing 
Association; 1979.
  21.  Awa AE. Hypno-behavioral approach – an adjunct to medication in 
the treatment of essential hypertension. Clinical Psychology and the 
Nigerian Society. 1984;372–386.
  22.  World Health Organization. Adherence to long term therapies: Evidence 
for action. Geneva: World Health Organization; 2003.
  23.  Rand CS, Weeks K. Measuring adherence with medication regimen in 
clinical care and research. In: Shumaker SA, Schron EB, Ockene JK, 
McBee WL, editors. The Handbook of Health Behavior Change. 
New York, NY: Springer Publishing; 1998.
  24.  Bernard S, Bloom BS. Daily regimen and compliance with treatment. 
BMJ. 2001;323:647.
  25.  Burnier M. Medication adherence and persistence as the cornerstone 
of effective antihypertensive therapy. Am J Hypertens. 2006;19: 
1190–1196.
  26.  Rosenstock IM. Why people use health services. Milbank Mem Fund Q. 
1966;44 Suppl:94–127.
  27.  Omeje O. Physiological Psychology. Enugu: Glanic Books; 2005.
  28.  Joint National Committee on Prevention, Detection, Evaluation 
and Treatment of High Blood Pressure. The Seventh Report of the 
Joint National Committee on Prevention, Detection, Evaluation and 
  Treatment of High Blood Pressure. JAMA. 2003;282:2560–2572.
  29.  Gerbino PP, Nightengale BS, Bramley TJ, Frech F. Effect of medication 
on compliance with antihypertensive therapy on blood pressure control. 
Am J Hypertens. 2004;17 Suppl 5:222.
  30.  Snider AJ, Oparil S. Hypertension. Chicago, IL; Budlong Press; 1976.
  31.  Durbar J. Issues in assessment. In: Cohen NSJ, editor. New Directions 
in Patient Compliance. New York, NY: Lexington Books; 1979.
  32.  Stephenson J. Non-compliance may cause half of antihypertensive drug 




Locus control on adherence to antihypertensives
  33.  Dubbar-Jacob J, Burke LE, Puczynski S. Clinical assessment and 
  management of adherence to medical regimens. In: Nicassions PM, 
Smith TW, editors. Managing Chronic Illness. Washington, DC: Ameri-
can Psychological Association; 1995.
  34.  Gottlieb H. Medication non-adherence: Finding solutions to a costly 
medical problem. Drug Benefit Trend. 2006;12:57–62.
  35.  Rotter JB. Generalized expectancies for internal versus external control 
of reinforcement. Psychol Monogr. 1966;33:300–303.
  36.  Wallston KA, Wallston BS. Who is responsible for your health? The 
construct of health locus of control. In: Sanders GS, Suls J, editors. 
Social Psychology of Health and Illness. Hillsdale NJ: Lawrence 
  Erlbaum and Associates; 1982.
  37.  Seaman M. Alienation and social learning in a reformatory. Am J Sociol. 
1963;9:270–284.
  38.  Wallston KA, Wallston BS, Devellis R. Development of the multidi-
mensional health locus of control scales. Health Educ Monogr. 1978;6: 
160–170.
  39.  Rodin J. Aging and health: Effects of the sense of control. Science. 
1986;233:1271–1276.
  40.  Carlise-Frank P. Examining personal control belief as a mediating vari-
able in health-demanding behaviors of substance use: An alternative 
approach. J Psychol. 1991;125:381–397.
  41.  Lau RC. Origins of health locus of control beliefs. J Pers Soc Psychol. 
1982;42:322–334.
  42.  Coan CN. Compliance in HIV/AIDS therapy: Why don’t patients take 
their pills? Can Med Assoc J. 2001;160:64–65.
  43.  Balch PN. Physician’s Guide to Compliance in Antiretroviral Therapy. 
Westpoint, PA: Merck & Co; 2005.
  44.  Lefcourt HM, Davidson-Keitz K. Locus of control and health. 
In: Snyder CR, Forsyth DR, editors. Handbook of Social and   
Clinical   Psychology. The Health Perspective. New York, NY: Pergamon 
Press; 1991.
  45.  Lewis EK. Role of viral load in the pathogens of HIV-2 infection in 
West Africa. Unpublished PhD thesis: Open University Abidjan; 2000.
  46.  Lefcourt KC. Locus of Control: Current Issues on Compliance to 
Antiretroviral Drugs. Hillsdale, MN: Erlbaum; 2001.
  47.  Phares EJ. Locus of Control in Personality. Mornstown, NJ: General 
Learning Press; 1976.
  48.  Morowatisharifabadi MA, Mahmoodabad SM, Baghiannimoghadam MH, 
Tonekaboni NR. Relationship between locus of control and adherence 
to diabetes regimen in a sample of Iranians. Int J Diab Dev Ctries. 
2010;30:27–32.
  49.  Guilford JP. Psychometric Methods. New York, NY: McGraw Hill; 1954.
  50.  Strickland BR. Internal-external expected and health related behaviors. 
J Consult Clin Psychol. 1978;46:1192–1211.
  51.  Urquhart J. Patient non-compliance with drug regimens: Measurement, 
clinical correlates, economic impact. Eur Heart J. 1996;17 Suppl A: 
8–15.
  52.  Dracup KA, Meleis AI. Compliance: An interactional approach. Nurs 
Res. 1982;31:31–36.Patient Preference and Adherence
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/patient-preference-and-adherence-journal
Patient Preference and Adherence is an international, peer-reviewed, 
open access journal focusing on the growing importance of patient 
preference and adherence throughout the therapeutic continuum. Patient 
satisfaction, acceptability, quality of life, compliance, persistence and 
their role in developing new therapeutic modalities and compounds to 
optimize clinical outcomes for existing disease states are major areas of 
interest. This journal has been accepted for indexing on PubMed Central. 
The manuscript management system is completely online and includes a 
very quick and fair peer-review system. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.








Please choose one of the four options below that best describes how you react to medical treatment.
Tick: (AA) for “almost always”; (O) for “often”; (s) for “sometimes”; or (r) for “rarely”
S/No AA O S R
1 i check my blood pressure regularly as advised by my doctor
2 i take my drugs regularly according to the schedule
3 i keep to my drugs even when my blood pressure has normalized
4 My antihypertensive drugs are readily available to me
5 I can cope financially with the purchase of my drugs
6 The adverse effects of the drugs on me make me abandon them
7 i go to my doctor for an alternative immediately i experience any adverse drug reactions
8 i take my drugs every time i remember to take them
9 i take my drugs with me whenever i travel to make sure i keep to the schedule
10 i adhere strictly to medical advice pertaining food, exercise, and other health habits
11 The cordial relationship between my doctor and i makes me adhere to the drugs prescribed
12 Lack of information about my treatment pattern affects my adherence to drugs prescribed
13 The severity of my illness affects my adherence to drugs
14 i stop taking my drugs whenever i feel they are not working and i feel worse with the drugs
15 i keep taking my drugs despite its long duration
16 i take my drugs even when i feel alright